Yayın Ağı
SCI, SSCI ve AHCI İndekslerine Giren Dergilerde Yayınlanan Makaleler
Diagnosis and Treatment of Autoimmune Hepatitis: Questions, Answers, and Illustrative Cases: Endorsed by Autoimmune Liver Diseases Special Interest Group, Turkish Association for the Study of Liver
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology
, cilt.34, 2023 (SCI-Expanded)
Development of metabolic disorders in transplant recipients
JOURNAL OF HEPATOLOGY
, cilt.78, 2023 (SCI-Expanded)
Nosocomial infections in cirrhosis are unpredictable and vary based on region of the world: CLEARED study
JOURNAL OF HEPATOLOGY
, cilt.78, 2023 (SCI-Expanded)
Five years follow-up of 96 weeks peginterferon plus tenofovir disoproxil fumarate in hepatitis D
JOURNAL OF HEPATOLOGY
, cilt.78, 2023 (SCI-Expanded)
Factors associated with the development of extrahepatic malignancy in patients with nonalcoholic fatty liver disease: a single-center longitudinal study
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
, cilt.34, sa.11, ss.1172-1177, 2022 (SCI-Expanded)
NATURAL DISEASE OUTCOMES IN PATIENT WITH NONALCOHOLIC FATTY LIVER DISEASE: A STUDY WITH PAIRED LIVER BIOPSIES
HEPATOLOGY
, cilt.76, 2022 (SCI-Expanded)
EFFECT OF PROGNOSTIC NONINVASIVE TESTS ON DISEASE OUTCOME OF ALCOHOL-RELATED LIVER DISEASE
HEPATOLOGY
, cilt.76, 2022 (SCI-Expanded)
FUNCTIONAL CURE WITH LONAFARNIB-BASED THERAPY IN CHRONIC HEPATITIS DELTA
HEPATOLOGY
, cilt.76, 2022 (SCI-Expanded)
Effectiveness of MRI methods in the assessment of hepatic steatosis in living liver donors
JOURNAL OF HEPATOLOGY
, cilt.77, 2022 (SCI-Expanded)
The course of COVID-19 infection in patients with chronic hepatitis B and Delta
JOURNAL OF HEPATOLOGY
, cilt.77, 2022 (SCI-Expanded)
Chronic hepatitis delta with normal ALT and hepatitis D viremia
JOURNAL OF HEPATOLOGY
, cilt.77, 2022 (SCI-Expanded)
Association between non-alcoholic fatty liver disease and extrahepatic malignancy
JOURNAL OF HEPATOLOGY
, cilt.75, 2021 (SCI-Expanded)
Etiology of Cirrhosis in Turkey: A National Cohort Study
JOURNAL OF HEPATOLOGY
, cilt.75, 2021 (SCI-Expanded)
Sequential development of acute autoimmune hepatitis may lead to a serious clinical picture in primary biliary cirrhosis
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
, cilt.27, sa.10, ss.1228-1229, 2015 (SCI-Expanded)
Using chimeric mice with humanized livers to predict human drug metabolism and a drug-drug interactions
Journal of Pharmacology and Experimental Therapeutics
, cilt.344, sa.2, ss.388-396, 2013 (SCI-Expanded)
Repopulation of liver endothelial cells, but not hepatocytes, by allogeneic hematopoietic cell transplants.
BLOOD
, cilt.98, sa.11, 2001 (SCI-Expanded)
Cirrhosis in Turner's syndrome: Case report and literature review
European Journal of Gastroenterology and Hepatology
, cilt.12, sa.6, ss.707-709, 2000 (SCI-Expanded)
Cladribine therapy in chronic lymphoproliferative disorders: Single center experience
BRITISH JOURNAL OF HAEMATOLOGY
, cilt.102, sa.1, ss.244, 1998 (SCI-Expanded)
Polymerase chain reaction for the detection of HCV-RNA: cryoglobulinaemia as a cause for false negative results.
Italian journal of gastroenterology and hepatology
, cilt.29, sa.3, ss.273-4, 1997 (SCI-Expanded)
Protein C, protein S and antithrombin III levels in nephrotic syndrome.
BLOOD
, cilt.88, sa.10, ss.2982, 1996 (SCI-Expanded)
Diğer Dergilerde Yayınlanan Makaleler
Hakemli Kongre / Sempozyum Bildiri Kitaplarında Yer Alan Yayınlar
REGIONAL DIFFERENCES IN ACUTE KIDNEY INJURY PREVALENCE, CLINICAL CHARACTERISTICS AND PATIENT OUTCOMES IN A MULTI-NATIONAL CONSORTIUM OF INPATIENTS WITH CIRRHOSIS
Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Massachusetts, Amerika Birleşik Devletleri, 10 - 14 Kasım 2023
GLOBAL PREVALENCE OF INFECTIONS AND IMPACT OF REGIONAL VARIATIONS ON OUTCOMES: MULTI-NATIONAL CONSORTIUM OF CIRRHOSIS STUDY
Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Massachusetts, Amerika Birleşik Devletleri, 10 - 14 Kasım 2023
PRIVATE INSURANCE ACCESS IS ASSOCIATED WITH HIGHER LIVER TRANSPLANT LISTING AND TRANSPLANT ACCESS AND LOWER MORTALITY COMPARED TO NATIONAL INSURANCES IN A LARGE MULTINATIONAL COHORT OF INPATIENTS WITH CIRRHOSIS
Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Massachusetts, Amerika Birleşik Devletleri, 10 - 14 Kasım 2023
NON - INVASIVE FIBROSIS MARKERS FOR ASSESMENT OF LIVER FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS DELTA
Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Massachusetts, Amerika Birleşik Devletleri, 10 - 14 Kasım 2023
A STUDY OF ACUTE LIVER INJURY ASSOCIATED WITH ORNIDAZOLE: ANALYSIS OF 82 CASES IN TURKIYE
Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Massachusetts, Amerika Birleşik Devletleri, 10 - 14 Kasım 2023
ALCOHOL-RELATED ETIOLOGY IS AN INDEPENDENT PREDICTOR OF INPATIENT MORTALITY IN PATIENTS WITH CIRRHOSIS IN A PROSPECTIVE GLOBAL CONSORTIUM
Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Massachusetts, Amerika Birleşik Devletleri, 10 - 14 Kasım 2023
MAGNETIC RESONANCE ELASTOGRAPHY AND TRANSIENT ELASTOGRAPGHY TO ASSESS HEPATIC STETAOSIS AND LIVER FIBROSIS IN THE LIVER TRANSPLANT SETTING
Liver Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), ELECTR NETWORK, 13 - 16 Kasım 2020, cilt.72
TREATMENT DISCONTINUATION IN HBEAG-NEGATIVE CHRONIC HEPATIT B IS A VIABLE OPTION IN NON-CIRRHOTIC GENOTYPE D CHRONIC HEPATITIS B PATIENTS
Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, Massachusetts, Amerika Birleşik Devletleri, 8 - 12 Kasım 2019, cilt.70
SIMILAR RISK OF HEPATOCELLULAR CARCINOMA (HCC) DEVELOPMENT DURING LONG-TERM ENTECAVIR (ETV) OR TENOFOVIR DISOPROXIL FUMARATE (TDF) THERAPY IN CAUCASIAN CHRONIC HEPATITIS B (CHB) PATIENTS
Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, Massachusetts, Amerika Birleşik Devletleri, 8 - 12 Kasım 2019, cilt.70
NATURAL HISTORY OF INACTIVE HBsAg CARRIERS: A 10-YEAR PROSPECTIVE FOLLOW-UP STUDY
Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, Massachusetts, Amerika Birleşik Devletleri, 8 - 12 Kasım 2019, cilt.70
ASSOCIATION BETWEEN NON-ALCOHOLIC FATTY LIVER DISEASE AND SUBCLINICAL ATHEROSCLEROSIS AND MYOCARDIAL DYSFUNCTION USING MULTIMODALITY IMAGING
Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, Massachusetts, Amerika Birleşik Devletleri, 8 - 12 Kasım 2019, cilt.70
TÜRKİYE’DE HEPATİT C ELİMİNASYONU YOL HARİTASI ÖNERİLERİ VE ÇALIŞTAY RAPORU
XI.Ulusal Viral Hepatit Simpozyumu, Türkiye, 14 - 16 Haziran 2019
Plasma metabolomic changes modulate the impact of Middle Eastern versus Western Diet in an international cirrhosis cohort
International Liver Congress / 54th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), Vienna, Avusturya, 10 - 14 Nisan 2019, cilt.70
Prediction and Need for Surveillance of Hepatocellular Carcinoma (HCC) Development after the First 5 Years of Entecavir (ETV) or Tenofovir Disoproxil Fumarate (TDF) Therapy in Caucasian Chronic Hepatitis B (CHB) Patients of the PAGE-B Cohort
Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, San-Francisco, Kostarika, 9 - 13 Kasım 2018, cilt.68
ALT Levels and Risk of Hepatocellular Carcinoma (HCC) in Caucasian Chronic Hepatitis B (CHB) Patients Under Long-Term Therapy with Entecavir (ETV) or Tenofovir Disoproxil Fumarate (TDF)
Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, San-Francisco, Kostarika, 9 - 13 Kasım 2018, cilt.68
Real world data on safety and efficacy of Ledipasvir Sofosbuvir ± RBV, Ombitasvir / Paritaprevir / Ritonavir ± Dasabuvir ± RBV combination therapy for chronic hepatitis C. A Turkey experience.
APASL Single Topic Conference, İstanbul, Türkiye, 27 - 29 Eylül 2018
HEPATİT C ENFEKSİYONUNA BAĞLI DEKOMPANZE SİROZ HASTALARINDA VE KRONİK HEPATİT C ENFEKSİYONU NEDENİYLE KARACİĞER NAKLİ OLANLARDA LEDİPASVİR/SOFOSBUVİR TEDAVİSİNİN ETKİLİLİĞİ: TÜRKİYE ERKEN ERİŞİM PROGRAMI SONUÇLARI
34. ULUSAL GASTROENTEROLOJİ HAFTASI, Türkiye, 1 - 06 Aralık 2017
EFFICIACY OF LEDİPASVİR AND SOFOSBUVİR WİTH/WİTHOUT TREATMENT OF CHRONIC HEPATITIS C PATIENTS WITH ADVANCED LIVER DISEASE RESULT OF A MULTICENTER TURKISH EARLY ACCES PROGRAM
VIRAL HEPATITIS (ENDORSED BY AASLD), 3 - 04 Mart 2017
Hepatocellular carcinoma (HCC) is the only factor affecting the excellent survival of Caucasian chronic hepatitis B (CHB) patients with or without cirrhosis under long-term entecavir (ETV) or tenofovir (TDF) therapy
67th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Massachusetts, Amerika Birleşik Devletleri, 11 - 15 Kasım 2016, cilt.64
The risk of hepatocellular carcinoma (HCC) is decreasing after the first 5 years of entecavir (ETV) or tenofovir (TDF) therapy in Caucasian chronic hepatitis B (CHB) patients
67th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Massachusetts, Amerika Birleşik Devletleri, 11 - 15 Kasım 2016, cilt.64
The Role Of Genetic Variability Of PNPLA3 (rs738409) On Predispotion To Non-Alcoholic Fatty Liver Disease In Lean Patients
67th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Massachusetts, Amerika Birleşik Devletleri, 11 - 15 Kasım 2016, cilt.64
The Prenylation Inhibitor Lonafarnib Can Induce Post-Treatment Alt Flares With Viral Clearance In Patients With Chronic Delta Hepatitis
67th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Massachusetts, Amerika Birleşik Devletleri, 11 - 15 Kasım 2016, cilt.64
High incidence of significant liver fibrosis among HBeAg-positive patients with low levels of ALT
67th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Massachusetts, Amerika Birleşik Devletleri, 11 - 15 Kasım 2016, cilt.64
Chronic hepatitis D is a greater risk factor for hepatocellular carcinoma development than chronic hepatitis B
67th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Massachusetts, Amerika Birleşik Devletleri, 11 - 15 Kasım 2016, cilt.64
Exploring Optimal Dosing Of Lonafarnib With Ritonavir For The Treatment Of Chronic Delta Hepatitis-Interim Results From The Lowr Hdv-2 Study
67th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Massachusetts, Amerika Birleşik Devletleri, 11 - 15 Kasım 2016, cilt.64
Hepatoselüler Kanserde Tedavi Yaklaşımı
Hepatoloji Okulu 2016, Türkiye, 13 - 15 Mayıs 2016
Hepatitis delta virus kinetics under the prenylation inhibitor lonafarnib suggest HDV metiadted suppression of HBV replication
51th Annual Meeting of the European Association for the Study of the Liver (EASL), 13 - 17 Nisan 2016
Hepatitis B (HBV) Reactivation Rate and Fate Among Multiple Myeloma Patients Receiving Lenalidomide Containing Regimens: A Single Center Experience
57th Annual Meeting of the American-Society-of-Hematology, Florida, Amerika Birleşik Devletleri, 5 - 08 Aralık 2015, cilt.126
Decreasing risk of hepatocellular carcinoma (HCC) development after the first 5 years of entecavir (ETV) or tenofovir (TDF) therapy in Caucasian chronic hepatitis B (CHB) patients
66th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), San-Francisco, Kostarika, 13 - 17 Kasım 2015, cilt.62
"Normal" Serum ALT/AST Level in Turkish Population
66th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), San-Francisco, Kostarika, 13 - 17 Kasım 2015, cilt.62
Prolongation of interferon therapy increases maintained virological response rates and improves the natural course of chronic delta hepatitis
66th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), San-Francisco, Kostarika, 13 - 17 Kasım 2015, cilt.62
Hepatitis C Seropositivity is not as high as Western Countries in the Population Born Between 1945-1965 According to Turkey Nationwide Hepatitis Prevalence Study (TURKHEP 2010)
66th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), San-Francisco, Kostarika, 13 - 17 Kasım 2015, cilt.62
Multiple Genetic Mutations Increasing Thrombotic Risk Predisposing Both Donor and Recipient Thrombotic Complications After Living Donor Liver Transplantation: A Case Report
21st Annual International Congress of the International-Liver-Transplant-Society (ILTS), Illinois, Amerika Birleşik Devletleri, 8 - 11 Temmuz 2015, cilt.99, ss.278
Vena Caval Replacement With Cadaveric Caval Graft for Living Donor Liver Transplantation in Budd-Chiari Syndrome Associated With Hydatid Cyst Surgery: A Case Report
21st Annual International Congress of the International-Liver-Transplant-Society (ILTS), Illinois, Amerika Birleşik Devletleri, 8 - 11 Temmuz 2015, cilt.99, ss.247-248
Prognostic factors for prediction of survival of hepatocellular cancer patients after selective internal radiation therapy
Annual Meeting of the Society-of-Nuclear-Medicine-and-Molecular-Imaging (SNMMI), Missouri, Amerika Birleşik Devletleri, 7 - 11 Haziran 2014, cilt.55
Hepatoselüler kanserli hastalarda selektif internal radyasyon tedavisi sonrası sağkalımı öngörmede prognostik faktörler
26.Ulusal Nükleer Tıp Kongresi, Türkiye, 16 - 20 Nisan 2014, ss.17
Early on-treatment HDV RNA kinetics are not predicitve for long-term response to a PEG-IFNa therapy of hepatitis delta
65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, Massachusetts, Amerika Birleşik Devletleri, 7 - 11 Kasım 2014, cilt.60
The long-term efficacy of combination of nucleos(t)ide analogue treatment and low dose hepatitis b immunoglobulin on posttransplant HBV recurrence
65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, Massachusetts, Amerika Birleşik Devletleri, 7 - 11 Kasım 2014, cilt.60
Prenylation inhibition with lonafarnib decreases hepatitis D levels in humans
65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, Massachusetts, Amerika Birleşik Devletleri, 7 - 11 Kasım 2014, cilt.60
Timing of hepatocellular carcinoma (HCC) development and predictability of a modified PAGE-B risk score in caucasian chronic hepatitis B (CHB) patients treated with entecavir (ETV) or tenofovir (TDF)
65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, Massachusetts, Amerika Birleşik Devletleri, 7 - 11 Kasım 2014, cilt.60
Inactive hepatitis B carriers are prone to HBsAg loss rather than reactivation: a 5-year prospective follow-up study
64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Washington, Kiribati, 1 - 05 Kasım 2013, cilt.58
Risk and risk factors of hepatocellular carcinoma (HCC) in Caucasian chronic hepatitis B (CHB) patients with or without cirrhosis treated with entecavir (ETV) or tenofovir (TDF)
64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Washington, Kiribati, 1 - 05 Kasım 2013, cilt.58
Effectiveness and safety of entecavir and tenofovir in chronic hepatitis b patients: A multicenter Turkish study in clinical practice
64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Washington, Kiribati, 1 - 05 Kasım 2013, cilt.58
Four years of tenofovir monotherapy for NUC naive field practice European patients suppresses HBV replication in most patients with a favorable renal safety profile but does not prevent HCC in patients with or without cirrhosis
64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Washington, Kiribati, 1 - 05 Kasım 2013, cilt.58
INTERLEUKIN-28 (IL-28) GENE POLYMORPHISM (RS12979860 C/T) IS ASSOCIATED WITH PROGRESSION TO CHRONIC DELTA HEPATITIS INFECTION
62nd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), San-Francisco, Kostarika, 4 - 08 Kasım 2011, cilt.54
IDENTIFICATION OF RISK FACTORS FOR FIBROSIS PROGRESSION IN NON-ALCOHOLIC FATTY LIVER DISEASE
61st Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, Massachusetts, Amerika Birleşik Devletleri, 29 Ekim - 02 Kasım 2010, cilt.52
RENAL TUBULER ACIDOSIS IN LIVER TRANSPLANT RECIPIENTS: THE EFFECT OF CALCINEURIN INHIBITORS.
15th Annual Congress of the International-Liver-Transplantation-Society, New York, Amerika Birleşik Devletleri, 8 - 11 Temmuz 2009, cilt.15
HBEAG-POSITIVE DELTA HEPATITIS: VIROLOGICAL; BIOCHEMICAL AND CLINICAL FEATURES IN A LARGE EUROPEAN MULTICENTER DATA BASE
59th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, San-Francisco, Kostarika, 31 Ekim - 04 Kasım 2008, cilt.48
Complete genome sequences and phylogenetic analysis of hepatitis D viruses (HDV) isolated from turkish patients with chronic HDV infection
58th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, Massachusetts, Amerika Birleşik Devletleri, 2 - 06 Kasım 2007, cilt.46
Potential role of cytokine gene polymorphisms in outcome of chronic delta hepatitis
57th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, Massachusetts, Amerika Birleşik Devletleri, 27 - 31 Ekim 2006, cilt.44
Insulin-sensitizer agents in the treatment of individuals with non-alcoholic steatohepatitis: A preliminary report
57th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, Massachusetts, Amerika Birleşik Devletleri, 27 - 31 Ekim 2006, cilt.44
The fate of recipient-derived repopulated hepatocytes in sex-mismatched liver allograft: A longitudinal study
56th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, San-Francisco, Kostarika, 11 - 15 Kasım 2005
Treatment of chronic hepatitis D (CHD) with interferon vs. interferon plus lamivudine vs. lamivudine: Short-and long-term results
56th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, San-Francisco, Kostarika, 11 - 15 Kasım 2005, cilt.42
Potential role of cytokine gene polymorphisms in hepatitis B infection outcome
40th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Paris, Fransa, 13 - 17 Nisan 2005, cilt.42, ss.230
PPAR-alpha L162V polymorphism in nonalcoholic steatohepatitis.
55th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Massachusetts, Amerika Birleşik Devletleri, 29 Ekim - 02 Kasım 2004, cilt.40
Recipient-derived hepatocytes in sex-mismatched living-related partial liver transplants.
54th Annual Meeting of the American-Association-for-the-Study-of-Liver-Disease, BOSTON, MASSACHUSETTS, 24 - 28 Ekim 2003
Lamivudine prophylaxis for prevention of chemotherapy induced hepatitis B virus reactivation in hepatitis B virus carriers with hematological malignancies
38th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, İstanbul, Türkiye, 29 Mart - 01 Nisan 2003, cilt.38, ss.146-147
The effect of hepatitis B virus status of the donor on the hepatitis B virus serology of the recipient after allogeneic hematopoietic cell transplantation
38th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, İstanbul, Türkiye, 29 Mart - 01 Nisan 2003, cilt.38, ss.146
The effect of mycophenolate mofetil in steroid refractory or dependent chronic graft-versus-host disease
29th Annual Meeting of the European Group for Blood and Marrow Transplantation/19th Meeting of the EBMT Nurses Group/2nd Meeting of the EBMT Data Management Group, İstanbul, Türkiye, 23 - 26 Mart 2003, cilt.31
The effect of hepatitis B virus status of donor on the hepatitis B virus serology of recipient after allogeneic hematopoietic cell transplantation
29th Annual Meeting of the European Group for Blood and Marrow Transplantation/19th Meeting of the EBMT Nurses Group/2nd Meeting of the EBMT Data Management Group, İstanbul, Türkiye, 23 - 26 Mart 2003, cilt.31
The efficciency of ursodeoxycholic acid in treatment of limited chronic graft versus host disease of the liver.
44th Annual Meeting of the American-Society-of-Hematology, PHILADELPHIA, PENNSYLVANIA, 6 - 10 Aralık 2002, cilt.100
The long-term ursodeoxycholic acid treatment of chronic graft-versus-host disease of the liver.
53rd Annual Meeting of the Association-for-the-Study-of-Liver-Diseases (AASLD), BOSTON, MASSACHUSETTS, 1 - 05 Kasım 2002, cilt.36
Kitap & Kitap Bölümleri
Türkiye Viral Hepatit Önleme ve Kontrol Programı” “Sağlık Bakanlığı Yayın No, Ankara
Sağlık Bakanlığı yayını Ankara, Ankara, 2018
Metrikler
BM Sürdürülebilir Kalkınma Amaçları
